Dissolution study of Spironolactone by using solid dispersion technique

Authors

  • Irwin Dewan Department of Pharmacy, University of Asia Pacific, Dhanmondi, Dhaka
  • SM Ashraful Islam Department of Pharmacy, University of Asia Pacific, Dhanmondi, Dhaka
  • Mohammad Shahriar Asst. Prof., Dept. of Pharmacy, UAP

DOI:

https://doi.org/10.3329/sjps.v4i2.7776

Keywords:

Solid dispersion, Spirinolactone, dissolution, Bioavailability

Abstract

The main objective of the current study was to formulate poorly water soluble drug Spirinolactone by using solid dispersion technique in order to achieve a better dissolution rate which would further help in enhancing oral bioavailability. Solid dispersions were prepared using two methods; solvent method and fusion method. Solid dispersion was prepared by using polymers, such as Hydroxy propylymethyl cellulose (HPMC 6cp), Hydroxy propyl cellulose (HPC), Sodium carboxymethylcellulose (Na-CMC), Povidone K12, Povidone K30, Poloxamer 407. Solid dispersions containing Spironolactone with HPC (96.81%), HPMC 6cp (93.05%), Poloxamer 407 (90.84%) and Na-CMC (89.93%) provided higher release rate than the release rate of solid dispersion containing only Spironolactone (35.27%), and Spironolactone with Povidone K12 (76.17%), Povidone K30 (67.92%). So the present study revealed that the solid dispersion may be an ideal means of drug delivery system for poorly water soluble drugs. Further study in this field was required to establish these drug delivery systems so that in future it can be used effectively in commercial basis.

DOI: http://dx.doi.org/10.3329/sjps.v4i2.7776

S. J. Pharm. Sci. 4(2) 2011: 42-47

Downloads

Download data is not yet available.
Abstract
197
PDF
198

Downloads

Published

2012-04-22

How to Cite

Dewan, I., Islam, S. A., & Shahriar, M. (2012). Dissolution study of Spironolactone by using solid dispersion technique. Stamford Journal of Pharmaceutical Sciences, 4(2), 42–47. https://doi.org/10.3329/sjps.v4i2.7776

Issue

Vol. 4 No. 2 (2011)

Section

Research Articles

License

As a condition of publication, all authors must transfer copyright to the Department of Pharmacy. Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed authors concur in the submission, and that the final version of the manuscript has been seen and approved by them.

Each author must agree to this statement

Authorship: This manuscript is the original work of the authors, each of whom has read and approved of the work. Each author satisfied the requirements contained in 'Author Guidelines' having participated sufficiently in the work to take public responsibility for the content. This participation includes:

  • Conception or design of the study, or analysis and interpretation of data, or both
  • Drafting the article or revising it for critically important intellectual content
  • Approval of the final 'to be published' version

All authors must take responsibility for the integrity of the work. Participating solely in the collection of data does not justify authorship.

Prior publication: This work is not currently under consideration by any other journal. Information about prior publication of any part of this work, or inclusion of patients detailed herein in any other work, has been provided in the cover letter.

Conflict of interest: Details of any financial or other relationship between any author and any other party that may lead to a conflict of interest with the subject or any materials mentioned in this article have been disclosed in the cover letter.